MedTrace Logo

Pancreatic Perfusion Using Secretin and MRI

NCT02458118 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2016-02-18

No results posted yet for this study

Summary

The purpose of this study is to assess pancreatic perfusion in patients with chronic pancreatitis at rest and after secretin stimulation and compare this to published data on pancreatic perfusion in normal subjects.

Conditions

  • Chronic Pancreatitis

Interventions

DRUG

Secretin

Secretin 1 IU/kg over 3 min

Sponsors & Collaborators

  • University of Nottingham

    lead OTHER

Principal Investigators

  • John Simpson · University of Nottingham

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2016-04-30
Completion
2016-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02458118 on ClinicalTrials.gov